Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Retatrutide for Sale > Peptide Powder Peptides Peptide Research Peptide Peptides Peptide Factory peptides peptides peptides peptide peptide research 5mg
Peptide Powder Peptides Peptide Research Peptide Peptides Peptide Factory peptides peptides peptides peptide peptide research 5mg buy - large image1
Peptide Powder Peptides Peptide Research Peptide Peptides Peptide Factory peptides peptides peptides peptide peptide research 5mg buy - image1
Peptide Powder Peptides Peptide Research Peptide Peptides Peptide Factory peptides peptides peptides peptide peptide research 5mg buy - image2
Peptide Powder Peptides Peptide Research Peptide Peptides Peptide Factory peptides peptides peptides peptide peptide research 5mg buy - image3
Peptide Powder Peptides Peptide Research Peptide Peptides Peptide Factory peptides peptides peptides peptide peptide research 5mg buy - image4
Peptide Powder Peptides Peptide Research Peptide Peptides Peptide Factory peptides peptides peptides peptide peptide research 5mg buy - image5
Peptide Powder Peptides Peptide Research Peptide Peptides Peptide Factory peptides peptides peptides peptide peptide research 5mg buy - image6

Peptide Powder Peptides Peptide Research Peptide Peptides Peptide Factory peptides peptides peptides peptide peptide research 5mg

6646 Inquiries

Unit Price: Get Latest Price
CAS No.:

2381089-83-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

Guangzhou

Brand:

Chunqiao

Packaging:

5mg 10mg 15mg 30mg per vial

Price valid (until):

2026-06-01

Company Type:
Trader
Location:
China
Qualification:
Main Products:

peptide

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


     Company Profile


    Guangzhou Chunqiao Trading Co., LTD., as an export enterprise specializing in peptide products and high-end biological raw materials, has steadily grown into a well-recognized supplier of peptide-based biological materials in the international market over the past decade. We focus on the R&D, production and global supply of active peptide products, peptide raw materials and customized peptide development services, and are committed to providing high-purity peptide products and professional biological application solutions for global customers.

    The company's products, featuring excellent purity, stable biological activity and consistent quality, are exported to more than 200 countries and regions worldwide, including Southeast Asia, Europe, North America, the Middle East, South America and Africa. We have built a solid reputation in overseas markets for adhering to strict quality control standards and meeting diverse customer needs. Relying on a professional technical team and global resource integration capabilities, we fully leverage Guangzhou's superior geographical location and sound supply chain advantages, continuously optimize cross-border supply chain management and localized operation services, and effectively help customers reduce procurement costs and improve operational efficiency while ensuring the stable supply of high-quality peptide products.

    With years of in-depth accumulation in the peptide industry and rich experience in international biological product trade, Guangzhou Chunqiao is not only a reliable peptide supplier but also a trustworthy professional biological raw material consultant for global partners. We are always dedicated to providing customized technical support, product application guidance and business development suggestions for clients, helping partners seize market opportunities in the biological industry and achieve win-win growth in the global market.

    We adhere to the service philosophy of "customer-centric, quality-oriented", and have established a comprehensive after-sales service system. We respond to customer inquiries and needs 7×24 hours a day, ensure timely resolution of product-related issues, and guarantee smooth and hassle-free cooperation for our partners around the world.

    Shop Peptide Powder Peptides Peptide Research Peptide Peptides Peptide Factory peptides peptides peptides peptide peptide research 5mg-Detailed Image 1
    Shop Peptide Powder Peptides Peptide Research Peptide Peptides Peptide Factory peptides peptides peptides peptide peptide research 5mg-Detailed Image 2
    Shop Peptide Powder Peptides Peptide Research Peptide Peptides Peptide Factory peptides peptides peptides peptide peptide research 5mg-Detailed Image 3
    Shop Peptide Powder Peptides Peptide Research Peptide Peptides Peptide Factory peptides peptides peptides peptide peptide research 5mg-Detailed Image 4
    Shop Peptide Powder Peptides Peptide Research Peptide Peptides Peptide Factory peptides peptides peptides peptide peptide research 5mg-Detailed Image 5
    Shop Peptide Powder Peptides Peptide Research Peptide Peptides Peptide Factory peptides peptides peptides peptide peptide research 5mg-Detailed Image 6
    Shop Peptide Powder Peptides Peptide Research Peptide Peptides Peptide Factory peptides peptides peptides peptide peptide research 5mg-Detailed Image 7
    Shop Peptide Powder Peptides Peptide Research Peptide Peptides Peptide Factory peptides peptides peptides peptide peptide research 5mg-Detailed Image 8
    Shop Peptide Powder Peptides Peptide Research Peptide Peptides Peptide Factory peptides peptides peptides peptide peptide research 5mg-Detailed Image 9
    Shop Peptide Powder Peptides Peptide Research Peptide Peptides Peptide Factory peptides peptides peptides peptide peptide research 5mg-Detailed Image 10
    Shop Peptide Powder Peptides Peptide Research Peptide Peptides Peptide Factory peptides peptides peptides peptide peptide research 5mg-Detailed Image 11
    Shop Peptide Powder Peptides Peptide Research Peptide Peptides Peptide Factory peptides peptides peptides peptide peptide research 5mg-Detailed Image 12
    ECHEMI Editorial Reference
    Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.

    Basic Info
    Product Name:

    Retatrutide

    Other Name:

    Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide

    CAS No.:

    2381089-83-2

    Molecular Formula:

    C221H342N46O68

    Molecular Weight:

    4731.33

    EC Number:

    200-001-8

    Color/Form:

    White lyophilized

    Characteristics
    Water Solubility:

    Soluble in water (5mg/ml).

    Storage Conditions:

    -20°C

    Critical Temperature & Pressure:

    -20°C

    Research
    Class:

    Triple agonist — GCGR, GIPR, GLP-1R

    Status:

    Investigational (Phase 3)

    Mechanism:

    Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

    EC50 (Human GCGR):

    5.79 nM

    EC50 (Mouse GIPR):

    0.191 nM

    EC50 (Mouse GLP1R):

    0.794 nM

    EC50 (Mouse GCGR):

    2.32 nM

    EC50 (Human GLP1R):

    0.775 nM

    EC50 (Human GIPR):

    0.0643 nM

    Source:

    Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

    Clinical Development:

    NCT04881760; NCT05882045; NCT06354660

    References
    ChEMBL:

    CHEMBL5095485

    DrugBank:

    DB18993

    KEGG DRUG:

    D12430

    PubChem:

    PubChem

    Disclaimer:

    Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    peptide

    Location:

    Unit 1-B2141, 19B-F1, 81-1 Nonglinxia Road, Yuexiu District, Guangzhou, China

    Year of Establishment:

    2026

    Company Profile
     

    Guangzhou Chunqiao Trading Co., Ltd.

    established in 202 6  and headquartered in Guangzhou  Province, is a comprehensive foreign trade enterprise integrating the research and development of peptides, raw material procurement, and sales. With a registered capital of 1 million USD and international certifications, our business spans 30 countries and regions, achieving an annual export volume exceeding 200 million USD. Leveraging a global supply chain system and a digital trading platform, we are dedicated to providing high-quality products and customized procurement solutions for overseas customers.

    Core Business and Products
    Our core operations encompass a cross-border trade agency, offering end-to-end services including import and export customs declaration, logistics clearance, and foreign exchange settlement. We also provide OEM/ODM services, specializing in product design, production, and private label processing for international brands. Furthermore, our supply chain management expertise allows us to integrate high-quality domestic manufacturing resources, establishing a vertical supply network from raw materials to finished goods. Our key product lines are in the chemical industry, focusing on raw materials, and the organic sector, featuring organic ecological products and plant extracts.
    Core Competitiveness

    • Full-chain service system: Establish a four-dimensional integrated system encompassing procurement, quality inspection, logistics and after-sales service, implementing a 48-hour rapid response mechanism with a customer complaint rate below 0.5%.

     

  • Inquiry History
    6646 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Retatrutide 2381089-83-2

    3 MT Mar 28, 2026
    United Kingdom

    Retatrutide - 2381089-83-2

    1 G Feb 10, 2026
    United States

    Retatrutide CAS 2381089-83-2 10mg vial

    20 MT Mar 7, 2026
    United States

    Factory Retatrutide API 99% Purity CAS 2381089-83-2

    5 KG Nov 10, 2025
    United Kingdom

    Peptide powder Retatrutide 99% pure for Body building cas 2381089-83-2 Weight Loss Peptide with COA

    1 MT Mar 22, 2026
    United States

    2381089-83-2

    100 G Jul 14, 2026
    United States

    2381089-83-2

    100 G Feb 24, 2026
    United States

    2381089-83-2

    100 MT Dec 9, 2023
    United States

    Retatrutide 2381089-83-2

    200 MG May 16, 2026
    United Kingdom

    2381089-83-2 retatrutide

    300 MG Feb 13, 2026
    United States

    Retatrutide 2381089-83-2 wholesale

    500 MT Nov 3, 2023
    United States

    Retatrutide CAS 2381089-83-2 99%

    10 PCS Feb 21, 2026
    Poland

    CAS 2381089-83-2 (Custom Peptide)

    40 MT Apr 10, 2026
    Austria

    Peptide Retatruide CAS 2381089-83-2

    100 MT Apr 4, 2026
    Austria

    Retatrutide CAS 2381089-83-2 10mg vial

    20 PCS Feb 10, 2026
    United States

    Tirzepatide 99.9% Liquid 2381089-83-2 TeruiOP

    1 MT Sep 6, 2023
    United States

    Retatrutide/LY3437943/GIPR/GLP-1R 98% Powder 2381089-83-2 Senwayer

    1 G Sep 3, 2023
    United States

    GLP-1 / GIP Retatrutide cas 2381089-83-2

    1 MT Oct 16, 2024
    United States

    Retatrutide 99% High Quality CAS 2381089-83-2

    1 G Jan 23, 2026
    United States

    Injection Peptide Tirzepatide/Retatrutide/ Semaglutide Peptides CAS 2381089-83-2

    10  Oct 21, 2023
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.